Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy-Reference-Cited by-同舟云学术

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy

Published:2020-10 Issue:1 Volume:28 Page:286-296
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur. J. Neurol.

Author:

Kuitwaard K.¹²^ORCID,Brusse E.¹,Jacobs B. C.¹³,Vrancken A. F. J. E.⁴,Eftimov F.⁵,Notermans N. C.⁴,Kooi A. J.⁵,Fokkink W. ‐J. R.¹³,Nieboer D.⁶,Lingsma H. F.⁶,Merkies I. S. J.⁷⁸,Doorn P. A.¹

Affiliation:

1. Department of Neurology Erasmus MC University Medical Centre Rotterdam Rotterdam The Netherlands

2. Department of Neurology Albert Schweitzer hospital Dordrecht The Netherlands

3. Department of Immunology Erasmus MC University Medical Center Rotterdam Rotterdam The Netherlands

4. Department of Neurology Brain Centre Rudolf Magnus University Medical Centre Utrecht Utrecht The Netherlands

5. Department of Neurology Amsterdam UMCUniversity of Amsterdam Amsterdam The Netherlands

6. Department of Public Health Erasmus MC University Medical Centre Rotterdam Rotterdam The Netherlands

7. Department of Neurology Curaçao Medical Centre Willemstad Willemstad Curaçao

8. Department of Neurology School of Medical Health and Neuroscience Maastricht University Medical Centre Maastricht The Netherlands

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.14501

Reference47 articles.

1. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society‐First Revision;J Peripher Nerv Syst,2010

2. A current view of the diagnosis, clinical variants, response to treatment and prognosis of chronic inflammatory demyelinating polyradiculoneuropathy

3. High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, crossover study

4. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, cross-over study

5. Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravenous immunoglobulin alleviates Japanese encephalitis virus-induced peripheral neuropathy by inhibiting the ASM/ceramide pathway;International Immunopharmacology;2024-05

2. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy;Cochrane Database of Systematic Reviews;2024-02-14

3. Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy: A Historical Perspective;Journal of Clinical Medicine;2023-11-07

4. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort;Journal of Neurology, Neurosurgery & Psychiatry;2023-10-25

5. Updated consensus statement: Intravenous immunoglobulin in the treatment of neuromuscular disorders report of the AANEM ad hoc committee;Muscle & Nerve;2023-07-11